Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The study met both the co-primary endpoint and all key secondary endpoints compared to placebo
As governments and insurers recognize the economic and healthcare burden of obesity, coverage and accessibility are set to improve, further accelerating market adoption
Revaccination may also be considered for patients who received 1 or more doses of COVID-19 vaccine during treatment with B-cell-depleting therapies (e.g., rituximab, ocrelizumab) that were administered over a limited period (e.g., as part of a treatment regimen for certain malignancies) according to the currently recommended schedule for people who are unvaccinated
Separately, the FDA has documented dosing errors with multidose vials in which patients received far more drug than intended
If an overdose is known to have occurred, treatment should focus on managing symptoms and providing supportive care
Its bigger than weight loss
